Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06314009
Other study ID # EH23-302
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 2024
Est. completion date December 2026

Study information

Verified date March 2024
Source NorthShore University HealthSystem
Contact Olivert Mbah
Phone 847-570-2243
Email OMbah@northshore.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the flow of oxygen and blood necessary for nutrient transfer across the placenta during the second and third trimesters in pregnancy in women who are obese before pregnancy compared to women who have an average weight before pregnancy. This study will evaluate blood flow across the placenta by functional Magnetic Resonance Imaging (fMRI) using arterial spin labeling (ASL). The investigators hypothesize that there will be differences in placental oxygenation and blood flow among women with obesity as compared to those with normal weight. Participants will be asked to complete Magnetic Resonance Imaging scans (MRIs), the first in the second trimester at 20-24 weeks and the second in the third trimester at 30-34 weeks.


Description:

The transfer of oxygen and nutrients from the mother to the baby across the placenta is essential to successful pregnancy outcomes. Conversely, poor transfer of oxygen from the mother to the baby through the placenta is associated with adverse outcomes, including poor fetal growth, preterm delivery, and stillbirth. Babies need oxygen to maintain good health. Babies born to women who are obese before pregnancy have a higher risk of experiencing health problems in pregnancy and long-term health problems such as metabolic syndrome, obesity, and diabetes. Obesity has continued to increase in the United States over the past decades, and a quarter of pregnancy complications, such as preterm birth, gestational diabetes, hypertension, and large gestational infants, can be attributed to maternal obesity. In this study, the investigators propose using a novel method, arterial spin labeling (ASL)) to measure placental blood flow. The study aims to evaluate the feasibility and reliability of assessing placental blood flow by this novel method. The investigators will also evaluate the mean global placental perfusion of second and third trimester placentas among obese women as compared to those with a normal weight before pregnancy. To provide an innovative and comprehensive evaluation of placental oxygen delivery and insights into the delivery of nutrients, investigators will compare global placental perfusion of second and third trimester placentas with measurements of placental oxygenation by R2* relaxation rates.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - singleton pregnancy Exclusion Criteria: - multifetal gestation - congenital anomaly - claustrophobia, or ineligible for MRI (incompatible implanted medical device)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
functional Magnetic Resonance Imaging (fMRI)
Participants will undergo a functional Magnetic Resonance Imaging (fMRI) using arterial spin labeling (ASL) and other Magnetic Resonance (MR) sequences

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
NorthShore University HealthSystem

Outcome

Type Measure Description Time frame Safety issue
Primary Inter - rater reliability of assessing placental blood flow by arterial spin labeling (ASL) Evaluated using a two-way mixed intraclass correlation coefficient for consistency 6 weeks after the delivery
Primary Mean placental perfusion in second and third trimester The mean global placental perfusion of second and third-trimester placentas among participants with obesity (Body Mass Index measured in kg/m^2, calculated using weight in kilograms and height in meters) as compared to those with a normal weight (kilograms) before pregnancy will be evaluated. 6 weeks after the delivery
Primary Mean R2* relaxation rates in second and third trimester the Mean R2* relaxation rates will be used to correlate the global placental perfusion of second and third trimester placentas with measurements of placental oxygenation. 6 weeks after the delivery
Secondary Perinatal outcomes including hypertensive disorders of pregnancy, gestational diabetes, preterm birth, small for gestational age, NICU admission, and stillbirth. The prevalence and incidence of outcomes such as hypertensive disorders of pregnancy, gestational diabetes, preterm birth, small for gestational age, NICU (Neonatal Intensive Care Unit) admission, stillbirth will be assessed. 6 weeks after the delivery
See also
  Status Clinical Trial Phase
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT04168606 - Study on Retroplacental Hematomas in Finistère
Completed NCT05771415 - Near-infrared Spectroscopy: Differences in Placental Oxygenation in Relation to Ultrasound Maturation Grade in physiologIcal Term Pregnancies
Completed NCT03764878 - MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function
Recruiting NCT03731949 - Placental Volume Analysis During Pregnanay
Not yet recruiting NCT06352970 - Effects of Tuberculosis Infection on Development and Function of the Placenta
Completed NCT05172674 - Ultrasound Diagnosis of Placental and Umbilical Cord Anomalies in Singleton Pregnancies Resulting From In-vitro Fertilization
Completed NCT06456645 - Effects of Smoking on Placenta and Lactation
Active, not recruiting NCT04488861 - The START Clinic: a Feasibility Study
Not yet recruiting NCT05284474 - Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler N/A
Not yet recruiting NCT05872009 - Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
Completed NCT03636698 - Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway
Active, not recruiting NCT05739097 - Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Completed NCT05245279 - Placental Perfusion in the Entire Placenta and With Sonobiopsy by Ultrasound N/A
Completed NCT05644964 - The Effect of Anemia in Adolescent and Advanced Age Pregnancies
Completed NCT03674606 - Trial of Early Screening Test for Pre-eclampsia and Growth Restriction Phase 4
Recruiting NCT04699578 - COVID-19 Infection and Fetal-neonatal Outcomes
Terminated NCT04525534 - Plasma Concentration of Biological Markers in Placenta Accreta Spectrum